Eli Lilly And Co (NYSE:LLY) today launched LillyDirect, a website that allows consumers with obesity to get prescriptions for its weight-loss drug Zepbound via telehealth, and offers home delivery options. The move stands in direct competition with WW International (WW), which bought telehealth provider Sequence to offer users access to drugs that suppress appetite, such as Novo Nordisk's (NVO) Ozempic and Wegovy.LLY was last seen up 1.6% at $627.50, and earlier surged to a record high of$631.18. Shares ar ...